Moderna to Present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference

Rhea-AI Summary

Moderna, Inc. (NASDAQ:MRNA) will have its CEO, Stéphane Bancel, participate in a fireside chat at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on January 6th, 2022, at 2:00 p.m. ET. A live webcast will be accessible in the Investors section of Moderna's website, with a replay available for 30 days post-event. Moderna has evolved over the past decade from an mRNA research-stage company to a leader in mRNA therapeutics and vaccines, contributing significantly to COVID-19 vaccine development.

CAMBRIDGE, MA / ACCESSWIRE/ January 4, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that CEO Stéphane Bancel will participate in a fireside chat at the Goldman Sachs 14^th Annual Healthcare CEOs Unscripted Conference on Thursday, January 6^th at 2:00 p.m. ET.

A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for 30 days following the presentation.

About Moderna

In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View source version on accesswire.com:
https://www.accesswire.com/680980/Moderna-to-Present-at-the-Goldman-Sachs-14th-Annual-Healthcare-CEOs-Unscripted-Conference

FAQ

When is Moderna presenting at the Goldman Sachs Healthcare Conference?

Moderna will present on January 6th, 2022, at 2:00 p.m. ET.

Who from Moderna will be speaking at the conference?

CEO Stéphane Bancel will participate in the fireside chat.

Where can I watch the Moderna presentation?

The presentation can be viewed live on Moderna's website under the Investors section.

How long will the webcast of the Moderna presentation be available?

The webcast will be archived for 30 days following the event.

What are Moderna's key advancements in the past decade?

Moderna has transformed into a leader in mRNA therapeutics and vaccines, notably for COVID-19.